Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-25-013340

Options or other derivatives

  • CMO & Head of Development acquired 286,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Watkins Tim CMO & Head of Development 2025-04-28 Grant or award · Stock Option (right to buy) +260,000 260,000 D: show line 1 in the form
Watkins Tim CMO & Head of Development 2025-04-28 Grant or award · Stock Option (right to buy) +26,000 26,000 D: show line 2 in the form
Loading xslF345X05/rdgdoc.xml…